Tecovirimat Use in Ambulatory and Hospitalized Patients with Monkeypox Virus Infection

En Ling Wu*, Rebecca L. Osborn, Christie M. Bertram, W. Justin Moore, Shannon R. Galvin, Maureen K. Bolon, Mary Clare Masters, Karen M. Krueger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

In this case series of 20 ambulatory and hospitalized adult patients treated for monkeypox virus at a large academic medical center in Chicago, Illinois, tecovirimat use was reserved for those with or at high risk of severe disease, delayed because of logistical and clinical factors, but well tolerated.

Original languageEnglish (US)
Pages (from-to)172-174
Number of pages3
JournalSexually Transmitted Diseases
Volume50
Issue number3
DOIs
StatePublished - Mar 1 2023

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases
  • Dermatology

Fingerprint

Dive into the research topics of 'Tecovirimat Use in Ambulatory and Hospitalized Patients with Monkeypox Virus Infection'. Together they form a unique fingerprint.

Cite this